Cargando…

Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011

Drug abuse has become a global issue of concern. It affects not only individual users, but also their families and communities. Data were retrieved from the database of the Taiwan Surveillance System of Drug Abuse and Addiction Treatment (SSDAAT) from 2002 to 2011, and 147,660 cases reported by medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Jui, Lin, Jii-Jun, Tsay, Wen-Ing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359320/
http://dx.doi.org/10.1016/j.jfda.2014.01.019
_version_ 1784764119075782656
author Hsu, Jui
Lin, Jii-Jun
Tsay, Wen-Ing
author_facet Hsu, Jui
Lin, Jii-Jun
Tsay, Wen-Ing
author_sort Hsu, Jui
collection PubMed
description Drug abuse has become a global issue of concern. It affects not only individual users, but also their families and communities. Data were retrieved from the database of the Taiwan Surveillance System of Drug Abuse and Addiction Treatment (SSDAAT) from 2002 to 2011, and 147,660 cases reported by medical institutions in Taiwan were reviewed. This study showed that the top five reported abused drugs by medical institutions during the last decade were heroin, methamphetamine, benzodiazepines, ketamine, and zolpidem. Heroin and methamphetamine continued to be the first two abused drugs reported by medical institutions. Heroin abuse was significant, but has shown a downward trend. However, emerging abused drugs, such as ketamine and zolpidem, presented upward trends. 3,4-Methylenedioxy-N-methylamphetamine (MDMA) abuse seems to have re-emerged and has increased gradually since 2010. Injection without needle sharing has become the most common route of administration of abused drugs since 2002. The majority of causes for these reported drug abuses were drug dependence, followed by peer influence and stress relief. Hepatitis C was the most commonly reported infectious disease, followed by hepatitis B and AIDS in the drug abusers reported by medical institutions. It should be noted that access to drugs via the Internet increased year by year, and this is clearly an area needing constant monitoring.
format Online
Article
Text
id pubmed-9359320
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taiwan Food and Drug Administration
record_format MEDLINE/PubMed
spelling pubmed-93593202022-08-09 Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011 Hsu, Jui Lin, Jii-Jun Tsay, Wen-Ing J Food Drug Anal Review Article Drug abuse has become a global issue of concern. It affects not only individual users, but also their families and communities. Data were retrieved from the database of the Taiwan Surveillance System of Drug Abuse and Addiction Treatment (SSDAAT) from 2002 to 2011, and 147,660 cases reported by medical institutions in Taiwan were reviewed. This study showed that the top five reported abused drugs by medical institutions during the last decade were heroin, methamphetamine, benzodiazepines, ketamine, and zolpidem. Heroin and methamphetamine continued to be the first two abused drugs reported by medical institutions. Heroin abuse was significant, but has shown a downward trend. However, emerging abused drugs, such as ketamine and zolpidem, presented upward trends. 3,4-Methylenedioxy-N-methylamphetamine (MDMA) abuse seems to have re-emerged and has increased gradually since 2010. Injection without needle sharing has become the most common route of administration of abused drugs since 2002. The majority of causes for these reported drug abuses were drug dependence, followed by peer influence and stress relief. Hepatitis C was the most commonly reported infectious disease, followed by hepatitis B and AIDS in the drug abusers reported by medical institutions. It should be noted that access to drugs via the Internet increased year by year, and this is clearly an area needing constant monitoring. Taiwan Food and Drug Administration 2014-02-15 /pmc/articles/PMC9359320/ http://dx.doi.org/10.1016/j.jfda.2014.01.019 Text en © 2014 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Review Article
Hsu, Jui
Lin, Jii-Jun
Tsay, Wen-Ing
Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011
title Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011
title_full Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011
title_fullStr Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011
title_full_unstemmed Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011
title_short Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011
title_sort analysis of drug abuse data reported by medical institutions in taiwan from 2002 to 2011
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359320/
http://dx.doi.org/10.1016/j.jfda.2014.01.019
work_keys_str_mv AT hsujui analysisofdrugabusedatareportedbymedicalinstitutionsintaiwanfrom2002to2011
AT linjiijun analysisofdrugabusedatareportedbymedicalinstitutionsintaiwanfrom2002to2011
AT tsaywening analysisofdrugabusedatareportedbymedicalinstitutionsintaiwanfrom2002to2011